Pharma Intelligence is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa

Register to Attend the Q1 Outlook Webinar: Key Catalysts and their Impact on Pharma Markets


Find out which market-moving events and catalysts to watch for during the upcoming Q1 Outlook Webinar - Key catalysts and their impact on pharma markets. During this free session, industry analysts from Informa Pharma Intelligence will present their data-based views on what’s in store for key drugs in early 2019.  Discussion will include important upcoming events related to these key drugs, their likelihood of phase/PDUFA review success and likelihood of approval, and an examination of the market significance of the drugs themselves.

Q1 Outlook Webinar - Key catalysts and their impact on pharma markets
Wednesday, February 27, 2019
4:00pm UK / 11:00am EST / 8:00am PST
Duration: 1 Hour

Presented by:

  • Michael Haydock, Therapeutic Area Director for Cardiovascular and Metabolic, and Infectious Diseases, Datamonitor Healthcare and Biomedtracker
  • Dominique Fontanilla, Therapeutic Area Director, CNS and Immunology and Inflammation, Datamonitor Healthcare and Biomedtracker
Highlights include:

  • The significance of key drugs mentioned in the Early 2019 Outlook Report
  • Top-line trial results, pivotal trial initiations, and expected regulatory filings, reviews, and approvals
  • Likelihood of Phase/PDUFA review success, overall Likelihood of Approval, and sales potential of key therapies






Pharma Intelligence. Copyright © 2019 Informa Plc.

This site is owned and operated by Informa plc ("informa") whose registered office is 5 Howick place, London SW1P 1WG. Registered in England and Wales Number 1072954.
Privacy Policy | Terms